EPS for Gevo, Inc. (GEVO) Expected At $-0.54, Nucor (NUE) Shorts Lowered By 0.08%

July 25, 2017 - By Louis Casey

Nucor Corporation (NYSE:NUE) had a decrease of 0.08% in short interest. NUE’s SI was 5.11 million shares in July as released by FINRA. Its down 0.08% from 5.12 million shares previously. With 2.73M avg volume, 2 days are for Nucor Corporation (NYSE:NUE)’s short sellers to cover NUE’s short positions. About 1.04M shares traded. Nucor Corporation (NYSE:NUE) has risen 21.74% since July 25, 2016 and is uptrending. It has outperformed by 5.04% the S&P500.

Analysts expect Gevo, Inc. (NASDAQ:GEVO) to report $-0.54 EPS on August, 8.They anticipate $2.46 EPS change or 82.00% from last quarter’s $-3 EPS. After having $-0.68 EPS previously, Gevo, Inc.’s analysts see -20.59% EPS growth. About 3.68M shares traded or 683.50% up from the average. Gevo, Inc. (NASDAQ:GEVO) has declined 85.24% since July 25, 2016 and is downtrending. It has underperformed by 101.94% the S&P500.

Among 19 analysts covering Nucor Corporation (NYSE:NUE), 13 have Buy rating, 0 Sell and 6 Hold. Therefore 68% are positive. Nucor Corporation had 52 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, June 19 by Longbow. The company was maintained on Thursday, September 15 by Jefferies. Argus Research maintained it with “Buy” rating and $75 target in Monday, December 12 report. The stock has “Buy” rating by Deutsche Bank on Monday, October 5. Credit Suisse maintained the shares of NUE in report on Wednesday, March 23 with “Neutral” rating. The stock of Nucor Corporation (NYSE:NUE) has “Overweight” rating given on Monday, February 13 by Morgan Stanley. The firm has “Buy” rating by Barclays Capital given on Friday, April 21. The stock of Nucor Corporation (NYSE:NUE) has “Overweight” rating given on Monday, February 6 by Barclays Capital. Barclays Capital maintained it with “Overweight” rating and $50 target in Monday, October 5 report. The stock has “Underperform” rating by Macquarie Research on Tuesday, November 29.

Investors sentiment increased to 1.03 in Q4 2016. Its up 0.06, from 0.97 in 2016Q3. It improved, as 49 investors sold Nucor Corporation shares while 230 reduced holdings. 106 funds opened positions while 180 raised stakes. 241.22 million shares or 0.70% more from 239.54 million shares in 2016Q3 were reported. Mitsubishi Ufj Tru holds 0.08% or 665,666 shares in its portfolio. State Bank Of Mellon Corporation reported 6.72 million shares. 9,000 are owned by Boys Arnold & Company. Benjamin F Edwards Company Inc has 0% invested in Nucor Corporation (NYSE:NUE). Jpmorgan Chase & Communication accumulated 0.02% or 1.16 million shares. The Montana-based First Interstate Commercial Bank has invested 0.01% in Nucor Corporation (NYSE:NUE). Mitsubishi Ufj Holdings Company Ltd holds 0.03% of its portfolio in Nucor Corporation (NYSE:NUE) for 90 shares. Allianz Asset Mngmt Ag reported 87,982 shares. Nomura Asset Mngmt Com Ltd reported 51,233 shares. Blackrock Advsrs Ltd Llc accumulated 596,158 shares or 0.04% of the stock. Northwestern Mutual Wealth Mngmt stated it has 0.01% in Nucor Corporation (NYSE:NUE). State Of Tennessee Treasury Department owns 408,697 shares. Segment Wealth Management Ltd Com accumulated 4,008 shares. Manning Napier Advsrs Llc, a New York-based fund reported 47,380 shares. Riverhead Capital Management Ltd Limited Liability Company holds 0.13% or 34,590 shares in its portfolio.

Nucor Corporation manufactures steel and steel products. The company has market cap of $19.66 billion. The Firm produces direct reduced iron (DRI) for use in its steel mills. It has a 16.83 P/E ratio. It operates in three divisions: steel mills, steel products and raw materials.

Since February 22, 2017, it had 0 buys, and 2 sales for $4.08 million activity. $3.29M worth of Nucor Corporation (NYSE:NUE) shares were sold by Frias James D. NAPOLITAN RAYMOND S JR also sold $790,425 worth of Nucor Corporation (NYSE:NUE) shares.

Gevo, Inc. is a renewable chemicals and next generation biofuels company. The company has market cap of $13.30 million. The Firm has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It currently has negative earnings. It has two operating divisions: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment.

Among 2 analysts covering Gevo (NASDAQ:GEVO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Gevo had 3 analyst reports since August 19, 2015 according to SRatingsIntel. Rodman & Renshaw initiated the stock with “Buy” rating in Wednesday, August 19 report. The rating was maintained by Rodman & Renshaw with “Buy” on Friday, January 13. On Wednesday, August 19 the stock rating was initiated by H.C. Wainwright with “Buy”.